Search Results - "Krett, Nancy L."

Refine Results
  1. 1

    Nuclear translocation of Atox1 potentiates activin A-induced cell migration and colony formation in colon cancer by Jana, Arundhati, Das, Archita, Krett, Nancy L, Guzman, Grace, Thomas, Alexandra, Mancinelli, Georgina, Bauer, Jessica, Ushio-Fukai, Masuko, Fukai, Tohru, Jung, Barbara

    Published in PloS one (21-01-2020)
    “…Colorectal cancer remains a deadly cancer due to metastatic disease. To understand the molecular mechanisms of metastasis in colon cancer, we investigated…”
    Get full text
    Journal Article
  2. 2

    Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy by McBrayer, Samuel K., Cheng, Javelin C., Singhal, Seema, Krett, Nancy L., Rosen, Steven T., Shanmugam, Mala

    Published in Blood (17-05-2012)
    “…Multiple myeloma is one of numerous malignancies characterized by increased glucose consumption, a phenomenon with significant prognostic implications in this…”
    Get full text
    Journal Article
  3. 3

    NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway by Jana, Arundhati, Krett, Nancy L, Guzman, Grace, Khalid, Ahmer, Ozden, Ozkan, Staudacher, Jonas J, Bauer, Jessica, Baik, Seung Hyun, Carroll, Timothy, Yazici, Cemal, Jung, Barbara

    Published in Oncotarget (06-06-2017)
    “…Colorectal cancer (CRC) remains a common and deadly cancer due to metastatic disease. Activin and TGFB (TGFβ) signaling are growth suppressive pathways that…”
    Get full text
    Journal Article
  4. 4

    Mechanisms of Glucocorticoid-mediated Apoptosis in Hematological Malignancies by GREENSTEIN, Stephanie, GHIAS, Kulsoom, KRETT, Nancy L, ROSEN, Steven T

    Published in Clinical cancer research (01-06-2002)
    “…Although glucocorticoids (GCs) have been used for their immunosuppressive, anti-inflammatory, and cytotoxic effects for many years, their precise mechanism of…”
    Get full text
    Journal Article
  5. 5

    Coencapsulation of Arsenic- and Platinum-based Drugs for Targeted Cancer Treatment by Chen, Haimei, Pazicni, Samuel, Krett, Nancy L, Ahn, Richard W, Penner-Hahn, James E, Rosen, Steven T, O'Halloran, Thomas V

    Published in Angewandte Chemie (International ed.) (01-01-2009)
    “…Two in one: A novel strategy for efficiently coencapsulating both arsenic‐ and platinum‐based drugs into 100 nm‐scale liposomes (NBs) relies on the formation…”
    Get full text
    Journal Article
  6. 6

    A collection of bioconductor methods to visualize gene-list annotations by Feng, Gang, Du, Pan, Krett, Nancy L, Tessel, Michael, Rosen, Steven, Kibbe, Warren A, Lin, Simon M

    Published in BMC research notes (19-01-2010)
    “…Gene-list annotations are critical for researchers to explore the complex relationships between genes and functionalities. Currently, the annotations of a gene…”
    Get full text
    Journal Article
  7. 7

    Targeting Glucose Consumption and Autophagy in Myeloma with the Novel Nucleoside Analogue 8-Aminoadenosine by Shanmugam, Mala, McBrayer, Samuel K., Qian, Jun, Raikoff, Kiril, Avram, Michael J., Singhal, Seema, Gandhi, Varsha, Schumacker, Paul T., Krett, Nancy L., Rosen, Steven T.

    Published in The Journal of biological chemistry (25-09-2009)
    “…Multiple myeloma, an incurable plasma cell malignancy, is characterized by altered cellular metabolism and resistance to apoptosis. Recent connections between…”
    Get full text
    Journal Article
  8. 8

    Integrative gene expression profiling reveals G6PD-mediated resistance to RNA-directed nucleoside analogues in B-cell neoplasms by McBrayer, Samuel K, Yarrington, Michael, Qian, Jun, Feng, Gang, Shanmugam, Mala, Gandhi, Varsha, Krett, Nancy L, Rosen, Steven T

    Published in PloS one (27-07-2012)
    “…The nucleoside analogues 8-amino-adenosine and 8-chloro-adenosine have been investigated in the context of B-lineage lymphoid malignancies by our laboratories…”
    Get full text
    Journal Article
  9. 9
  10. 10

    8-Amino-adenosine is a potential therapeutic agent for multiple myeloma by Krett, Nancy L, Davies, Katharine M, Ayres, Mary, Ma, Chunguang, Nabhan, Chadi, Gandhi, Varsha, Rosen, Steven T

    Published in Molecular cancer therapeutics (01-11-2004)
    “…Multiple myeloma (MM) is a malignancy of clonal B-cells that accounts for 10% of all hematologic malignancies. We have shown previously that a novel purine…”
    Get full text
    Journal Article
  11. 11

    Steroid receptor and microRNA regulation in cancer by Tessel, Michael A, Krett, Nancy L, Rosen, Steven T

    Published in Current opinion in oncology (01-11-2010)
    “…PURPOSE OF REVIEWSteroid hormone receptors (SHR) are crucial regulators of disease and the basis for clinical intervention in cancers. Recent evidence confirms…”
    Get full text
    Journal Article
  12. 12

    TGFβ and activin A in the tumor microenvironment in colorectal cancer by Zessner-Spitzenberg, Jasmin, Thomas, Alexandra L, Krett, Nancy L, Jung, Barbara

    Published in Gene reports (01-12-2019)
    “…Although overall survival in colorectal cancer (CRC) is increasing steadily due to progress in screening, therapeutic options and precise diagnostic tools…”
    Get full text
    Journal Article
  13. 13

    Identification of p38β as a Therapeutic Target for the Treatment of Sézary Syndrome by Bliss-Moreau, Meghan, Coarfa, Cristian, Gunaratne, Preethi H., Guitart, Joan, Krett, Nancy L., Rosen, Steven T.

    Published in Journal of investigative dermatology (01-02-2015)
    “…Cutaneous T-cell lymphomas (CTCLs) represent a group of hematopoietic malignancies that home to the skin and have no known molecular basis for disease…”
    Get full text
    Journal Article
  14. 14
  15. 15

    8-Amino-adenosine activates p53-independent cell death of metastatic breast cancers by Polotskaia, Alla, Hoffman, Sandy, Krett, Nancy L, Shanmugam, Mala, Rosen, Steven T, Bargonetti, Jill

    Published in Molecular cancer therapeutics (01-11-2012)
    “…8-Amino-adenosine (8-NH(2)-Ado) is a ribose sugar nucleoside analogue that reduces cellular ATP levels and inhibits mRNA synthesis. Estrogen receptor-negative…”
    Get full text
    Journal Article
  16. 16

    Inhibition of Glycogen Synthase Kinase-3 Increases the Cytotoxicity of Enzastaurin by Rovedo, Mark A., Krett, Nancy L., Rosen, Steven T.

    Published in Journal of investigative dermatology (01-07-2011)
    “…Cutaneous T-cell lymphomas (CTCL) represent a spectrum of several distinct non-Hodgkin's lymphomas that are characterized by an invasion of the skin by…”
    Get full text
    Journal Article
  17. 17

    Lipid Encapsulation of Arsenic Trioxide Attenuates Cytotoxicity and Allows for Controlled Anticancer Drug Release by Chen, Haimei, MacDonald, Robert C, Li, Shuyou, Krett, Nancy L, Rosen, Steven T, O'Halloran, Thomas V

    Published in Journal of the American Chemical Society (18-10-2006)
    “…Arsenic trioxide (ATO, As2O3) is emerging as a front line agent for treatment of acute promyelocytic leukemia with giving a complete remission rate of 83−95%…”
    Get full text
    Journal Article
  18. 18

    The Selective Protein Kinase C β Inhibitor Enzastaurin Induces Apoptosis in Cutaneous T-Cell Lymphoma Cell Lines through the AKT Pathway by Querfeld, Christiane, Rizvi, Mujahid A., Kuzel, Timothy M., Guitart, Joan, Rademaker, Alfred, Sabharwal, Simran S., Krett, Nancy L., Rosen, Steven T.

    Published in Journal of investigative dermatology (01-07-2006)
    “…Enzastaurin displays pro-apoptotic properties against a spectrum of malignancies and is currently being investigated in clinical trials. We have investigated…”
    Get full text
    Journal Article
  19. 19

    Inhibition of ATP synthase by chlorinated adenosine analogue by Chen, Lisa S., Nowak, Billie J., Ayres, Mary L., Krett, Nancy L., Rosen, Steven T., Zhang, Shuxing, Gandhi, Varsha

    Published in Biochemical pharmacology (15-09-2009)
    “…Phosphorylated metabolites of 8-chloroadenosine (8-Cl-Ado). Phosphorylation of 8-Cl-ADP by ATP synthase to form 8-Cl-ATP and subsequent inhibition of ATP…”
    Get full text
    Journal Article
  20. 20

    Enzastaurin (LY317615), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines by Rizvi, Mujahid A., Ghias, Kulsoom, Davies, Katharine M., Ma, Chunguang, Weinberg, Frank, Munshi, Hidayatullah G., Krett, Nancy L., Rosen, Steven T.

    Published in Molecular cancer therapeutics (01-07-2006)
    “…Enzastaurin (LY317615), an acyclic bisindolylmaleimide, is an oral inhibitor of the protein kinase Cβ isozyme. The objective of this study was to assess the…”
    Get full text
    Journal Article